First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: Microbiology, epidemiology and clinical outcomes

International Journal of Antimicrobial Agents

Volumn 37, Issue 6, 2011, Pages 513-518

  Van Der Bij, A K ^a   Van Mansfeld, R ^b   Peirano, G ^c   Goessens, W H F ^a   Severin, J A ^a   Pitout, J D D ^c,d   Willems, R ^b   Van Westreenen, M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c CALGARY LABORATORY SERVICES   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Metallo lactamase; Nosocomial; Prevalence; Pseudomonas aeruginosa; VIM 2

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; IMIPENEM; PENICILLIN G; PENICILLINASE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNCLASSIFIED DRUG; VIM 2 METALLO BETA LACTAMASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BLA VIM 2 GENE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; GENE LOCUS; GENE SEQUENCE; GENOTYPE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INTEGRON; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MOLECULAR BIOLOGY; MOLECULAR CLONING; NETHERLANDS; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TERTIARY HEALTH CARE; VARIABLE NUMBER OF TANDEM REPEAT; VIM 2 METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; IMIPENEM; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MOLECULAR TYPING; NETHERLANDS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 79955482781     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.02.010     Document Type: Article

References (32)

1. N. al Naiemi, M.C. Rijnsburger, P.H. Savelkoul, C.M. Vandenbroucke- Grauls, and Y.J. Debets-Ossenkopp Emergence of metallo-β-lactamases in The Netherlands J Med Microbiol 58 2009 1398 1399
2. T.R. Walsh Clinically significant carbapenemases: an update Curr Opin Infect Dis 21 2008 367 371
3. K.B. Laupland, M.D. Parkins, D.L. Church, D.B. Gregson, T.J. Louie, and J.M. Conly Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-β-lactamase (MBL)-producing strains J Infect Dis 192 2005 1606 1612 (Pubitemid 41504696)
4. A.P. Zavascki, A.L. Barth, A.L. Gonalves, A.L. Moro, J.F. Fernandes, and A.F. Martins The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections J Antimicrob Chemother 58 2006 387 392 (Pubitemid 44294952)
5. T.R. Walsh, M.A. Toleman, L. Poirel, and P. Nordmann Metallo-β- lactamases: the quiet before the storm? Clin Microbiol Rev 18 2005 306 325
6. V. Gupta Metallo-β-lactamases in Pseudomonas aeruginosa and Acinetobacter species Expert Opin Investig Drugs 17 2008 131 143 (Pubitemid 351578196)
7. S. Corvec, L. Poirel, E. Espaze, C. Giraudeau, H. Drugeon, and P. Nordmann Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme J Hosp Infect 68 2008 73 82
8. J.D. Pitout, B.L. Chow, D.B. Gregson, K.B. Laupland, S. Elsayed, and D.L. Church Molecular epidemiology of the metallo-β-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates J Clin Microbiol 45 2007 294 298
9. C. Peňa, C. Suarez, F. Tubau, O. Gutierrez, A. Dominguez, and A. Oliver Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications Clin Microbiol Infect 13 2007 1026 1029 (Pubitemid 47382261)
10. J.D. Pitout, G. Revathi, B.L. Chow, B. Kabera, S. Kariuki, and P. Nordmann Metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary care centre in Kenya Clin Microbiol Infect 14 2008 755 759
11. J. Elias, C. Schoen, G. Heinze, G. Valenza, E. Gerharz, and H. Riedmiller Nosocomial outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography Clin Microbiol Infect 2009 10.1111/j.1469-0691.2009.03146.x [Epub ahead of print]
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
13. J.D. Pitout, D.B. Gregson, L. Poirel, J.A. McClure, P. Le, and D.L. Church Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory J Clin Microbiol 43 2005 3129 3135 (Pubitemid 40981312)
14. R. Van Mansfeld, I. Jongerden, M. Bootsma, A. Buiting, M. Bonten, and R. Willems The population genetics of Pseudomonas aeruginosa isolates from different patient populations exhibits high-level host specificity PLoS One 5 2010 e13482
15. H. Vu-Thien, G. Corbineau, K. Hormigos, B. Fauroux, H. Corvol, and A. Clément Multiple-locus variable-number tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients J Clin Microbiol 45 2007 3175 3183 (Pubitemid 47585637)
16. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332 [Erratum in: Am J Infect Control 2008;36:655] (Pubitemid 351763841)
17. N.D. Friedman, K.S. Kaye, J.E. Stout, S.A. McGarry, S.L. Trivette, and J.P. Briggs Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 2002 791 797 (Pubitemid 35334450)
18. L. Poirel, T. Naas, D. Nicolas, L. Collet, S. Bellais, and J.D. Cavallo Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France Antimicrob Agents Chemother 44 2000 891 897 (Pubitemid 30165266)
19. VIM-2 carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes Antimicrob Agents Chemother 45 2001 546 552 (Pubitemid 32106716)
20. European Antimicrobial Resistance Surveillance System EARSS annual report 2008. On-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa 2009 National Institute for Public Health and the Environment (RIVM) Bilthoven, The Netherlands
21. M. Tomás, M. Doumith, M. Warner, J.F. Turton, A. Beceiro, and G. Bou Efflux pumps, OprD porin, AmpC β-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients Antimicrob Agents Chemother 54 2010 2219 2224
22. O. Cardoso, A.F. Alves, and R. Leitao Metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient Int J Antimicrob Agents 31 2008 375 379
23. S.K. Fridkin Increasing prevalence of antimicrobial resistance in intensive care units Crit Care Med 29 4 Suppl. 2001 N64 N68
24. O. Samuelsen, M.A. Toleman, A. Sundsfjord, J. Rydberg, T.M. Leegaard, and M. Walder Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion Antimicrob Agents Chemother 54 2010 346 352
25. S. Quinteira, J.C. Sousa, and L. Peixe Characterization of In100, a new integron carrying a metallo-β-lactamase and a carbenicillinase, from Pseudomonas aeruginosa Antimicrob Agents Chemother 49 2005 451 453 (Pubitemid 40065831)
26. C.G. Giske, B. Libisch, C. Colinon, E. Scoulica, L. Pagani, and M. Füzi Establishing clonal relationships between VIM-1-like metallo-β-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing J Clin Microbiol 44 2006 4309 4315 (Pubitemid 44937057)
27. B. Libisch, J. Watine, B. Balogh, M. Gacs, M. Muzslay, and G. Szabó Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary Res Microbiol 159 2008 162 168
28. A. Tsakris, A. Poulou, I. Kristo, T. Pittaras, N. Spanakis, and S. Pournaras Large dissemination of VIM-2-metallo-β-lactamase-producing Pseudomonas aeruginosa strains causing health care-associated community-onset infections J Clin Microbiol 47 2009 3524 3529
29. E. Edalucci, R. Spinelli, L. Dolzani, M.L. Riccio, V. Dubois, and E.A. Tonin Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa Clin Microbiol Infect 13 2008 88 90 (Pubitemid 350226577)
30. Y. Hirakata, T. Yamaguchi, M. Nakano, K. Izumikawa, M. Mine, and S. Aoki Clinical and bacteriological characteristics of IMP-type metallo-β- lactamase-producing Pseudomonas aeruginosa Clin Infect Dis 37 2003 26 32 (Pubitemid 36836641)
31. A.P. Zavascki, A.L. Barth, J.F. Fernandes, A.L. Moro, A.L. Gonalves, and L.Z. Goldani Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study Crit Care 10 2006 R114
32. A.P. Zavascki, A.L. Barth, and L.Z. Goldani Nosocomial bloodstream infections due to metallo-β-lactamase-producing Pseudomonas aeruginosa J Antimicrob Chemother 61 2008 1183 1185 (Pubitemid 351524470)